Synthetic and natural iron chelators: Therapeutic potential and clinical use

Parkinson's Disease

Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works

Oxygen toxicity, oxygen radicals, transition metals and disease

Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330 · see citing works

[1] Role of free radicals and catalytic metal ions in human disease: An overview

Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994 · see citing works

Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · see citing works

Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships

Heim, K. E., Tagliaferro, A. R., & Bobilya, D. J. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00208-5 · Cited by 4,261 · see citing works

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies

Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.230s · Cited by 4,219 · see citing works

Cloning and characterization of a mammalian proton-coupled metal-ion transporter

Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · see citing works

The biochemistry and medical significance of the flavonoids

Havsteen, B. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672 · see citing works

The ferritins: molecular properties, iron storage function and cellular regulation

Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667 · see citing works

Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications

Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,308 · see citing works

Disorders of Iron Metabolism

Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130 · see citing works

Curcumin: From ancient medicine to current clinical trials

Hatcher, H., Planalp, R. P., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,847 · see citing works

Balancing Acts

Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736 · see citing works

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · see citing works

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · see citing works

Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies

Williamson, G., & Manach, C. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.243s · Cited by 1,340 · see citing works

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis

Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275 · see citing works

Regulation of ferritin genes and protein

Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · see citing works

Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene

Fleming, M. D., Trenor, C. C., Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., & Andrews, N. C. (1997) · Nature Genetics · doi:10.1038/ng0897-383 · Cited by 1,159 · see citing works

Pharmacological and Clinical Aspects of Heme Oxygenase

Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115 · see citing works

Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse

Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084 · see citing works

Interleukin-6 induces hepcidin expression through STAT3

Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983 · see citing works

IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK

Sullivan, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92463-6 · Cited by 969 · see citing works

<i>Nramp</i> <i>2</i> is mutated in the anemic Belgrade ( <i>b</i> ) rat: Evidence of a role for Nramp2 in endosomal iron transport

Fleming, M. D., Romano, M. A., Su, M. A., Garrick, L. M., Garrick, M. D., & Andrews, N. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1148 · Cited by 936 · see citing works

Enterobactin: an archetype for microbial iron transport.

Raymond, K. N., Dertz, E. A., & Kim, S. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630018100 · Cited by 933 · see citing works

Tannins: classification and definition.

Khanbabaee, K., & van Ree, T. (2001) · Natural Product Reports · doi:10.1039/b101061l · Cited by 821 · see citing works

The roles of iron in health and disease

Lieu, P. T., Heiskala, M. K., Peterson, P. A., & Yang, Y. M. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00006-6 · Cited by 813 · see citing works

Chemistry and biology of eukaryotic iron metabolism

Aisen, P. (2001) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804 · see citing works

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells

Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775 · see citing works

Flavan‐3‐ols: Nature, occurrence and biological activity

Aron, P. M., & Kennedy, J. A. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700137 · Cited by 770 · see citing works

Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes

Guo, Q., Zhao, B., Li, M., Shen, S., & Xin, W. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00122-1 · Cited by 767 · see citing works

The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer

Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721 · see citing works

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

Cappellini, M. D. (2005) · Blood · doi:10.1182/blood-2005-08-3430 · Cited by 720 · see citing works

Green tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice

Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1521-05.2005 · Cited by 713 · see citing works

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 706 · see citing works

Ferritin for the clinician

Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.08.001 · Cited by 666 · see citing works

Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (pinus maritima) bark, pycnogenol

Packer, L., Rimbach, G., & Virgili, F. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00090-8 · Cited by 660 · see citing works

Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures

Morel, I., Lescoat, G., Cogrel, P., Sergent, O., Pasdeloup, N., Brissot, P., Cillard, P., & Cillard, J. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90371-3 · Cited by 635 · see citing works

Forging a field: the golden age of iron biology.

Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623 · see citing works

Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · see citing works

A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression

Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · see citing works

STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation

Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567 · see citing works

Dietary polyphenols: Good, bad, or indifferent for your health?

Halliwell, B. B. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.004 · Cited by 558 · see citing works

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554 · see citing works

A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

Whitnall, M., Howard, J., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604979103 · Cited by 510 · see citing works

Siderophores in Fungal Physiology and Virulence

Haas, H., Eisendle, M., & Turgeon, B. G. (2008) · Annual Review of Phytopathology · doi:10.1146/annurev.phyto.45.062806.094338 · Cited by 451 · see citing works

A Randomized Trial Comparing the Effect of Casein With That of Soy Protein Containing Varying Amounts of Isoflavones on Plasma Concentrations of Lipids and Lipoproteins

Crouse, J. R., Morgan, T. M., Terry, J. G., Ellis, J., Vitolins, M. Z., & Burke, G. L. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.17.2070 · Cited by 449 · see citing works

Proanthocyanidins in Health Care: Current and New Trends

Cos, P., Bruyne, T. D., Hermans, N., Apers, S., Berghe, D. A. V., & Vlietinck, A. J. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365288 · Cited by 441 · see citing works

The Molecular Mechanism of Hepcidin-mediated Ferroportin Down-Regulation

De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., & Kaplan, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0060 · Cited by 434 · see citing works

Soy protein, phytate, and iron absorption in humans

Hurrell, R. F., Juillerat, M., Reddy, M., Lynch, S., Dassenko, S., & Cook, J. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.3.573 · Cited by 425 · see citing works

The Role of Iron in Diabetes and Its Complications

Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423 · see citing works

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

Anderson, L. J., Westwood, M. A., Holden, S., Davis, B. A., Prescott, E., Wonke, B., Porter, J. B., Walker, J. M., & Pennell, D. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05202.x · Cited by 411 · see citing works

Metal chelation of polyphenols

Hider, R. C., Liu, Z. D., & Khodr, H. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)35243-6 · Cited by 410 · see citing works

Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract

Bagchi, D., Sen, C. K., Ray, S. D., Das, D. K., Bagchi, M., Preuss, H. G., & Vinson, J. A. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00324-x · Cited by 405 · see citing works

Total Cranberry Extract versus Its Phytochemical Constituents: Antiproliferative and Synergistic Effects against Human Tumor Cell Lines

Seeram, N. P., Adams, L. S., Hardy, M. L., & Heber, D. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0352778 · Cited by 404 · see citing works

Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells

Mezei, O., Shay, N. F., Banz, W. J., Steger, R. W., Peluso, M. R., & Winters, T. A. (2003) · Journal of Nutrition · doi:10.1093/jn/133.5.1238 · Cited by 401 · see citing works

NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke

Kahles, T., Luedike, P., Endres, M., Galla, H., Steinmetz, H., Busse, R., Neumann‐Haefelin, T., & Brandes, R. P. (2007) · Stroke · doi:10.1161/strokeaha.107.489765 · Cited by 386 · see citing works

Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment

Yuan, J. J., Lovejoy, D. B., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-03-0868 · Cited by 382 · see citing works

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

Borgna‐Pignatti, C. (2005) · Blood · doi:10.1182/blood-2005-07-2933 · Cited by 377 · see citing works

Oxidative Stress and Iron Homeostasis: Mechanistic and Health Aspects

Galaris, D., & Pantopoulos, K. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701713104 · Cited by 352 · see citing works

The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents

Richardson, D. R., Tran, E., & Ponka, P. (1995) · Blood · doi:10.1182/blood.v86.11.4295.bloodjournal86114295 · Cited by 350 · see citing works

Iron imports. IV. Hepcidin and regulation of body iron metabolism

Ganz, T., & Nemeth, E. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2005 · Cited by 347 · see citing works

Multifunctional Activities of Green Tea Catechins in Neuroprotection

Mandel, S. A., Avramovich‐Tirosh, Y., Reznichenko, L., Zheng, H., Weinreb, O., Amit, T., & Youdim, M. B. H. (2005) · Neurosignals · doi:10.1159/000085385 · Cited by 347 · see citing works

Myelodysplastic Syndromes — Coping with Ineffective Hematopoiesis

Cazzola, M., & Malcovati, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmp048266 · Cited by 342 · see citing works

Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults ☆ ☆Mention of trade name, proprietary product, or specific equipment does not constitute a guarantee by the US Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable.

Youdim, K. A., McDonald, J., Kalt, W., & Joseph, J. A. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(01)00221-2 · Cited by 319 · see citing works

Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity

Spencer, J. P. E., Mohsen, M. M. A. E., & Rice-Evans, C. A. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.11.010 · Cited by 317 · see citing works

Green Tea Epigallocatechin-3-Gallate Mediates T Cellular NF-κB Inhibition and Exerts Neuroprotection in Autoimmune Encephalomyelitis

Aktaş, O., Prozorovski, T., Тихоновна, С. А., Savaskan, N. E., Lauster, R., Kloetzel, P., Infante‐Duarte, C., Brocke, S., & Zipp, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5794 · Cited by 316 · see citing works

Interaction of Iron with Polyphenolic Compounds: Application to Antioxidant Characterization

Yoshino, M., & Murakami, K. (1998) · Analytical Biochemistry · doi:10.1006/abio.1997.2522 · Cited by 291 · see citing works

Antioxidant Activities and Antitumor Screening of Extracts from Cranberry Fruit ( Vaccinium macrocarpon )

Yan, X., Murphy, B. T., Hammond, G. B., Vinson, J. A., & Neto, C. C. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0202234 · Cited by 282 · see citing works

Oxidants in Chronic Kidney Disease

Shah, S. V., Baliga, R., Rajapurkar, M. M., & Fonseca, V. A. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050500 · Cited by 277 · see citing works

Effects of pH and Metal Ions on Antioxidative Activities of Catechins

Kumamoto, M., Sonda, T., NAGAYAMA, K., & Tabata, M. (2001) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.65.126 · Cited by 275 · see citing works

Design of clinically useful iron(III)‐selective chelators

Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266 · see citing works

Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator

Jiao, Y., Wilkinson, J., Di, X., Wang, W., Hatcher, H., Kock, N. D., D'Agostino, R., Knovich, M. A., Torti, F. M., & Torti, S. V. (2009) · Blood · doi:10.1182/blood-2008-05-155952 · Cited by 266 · see citing works

Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment

Ibrahim, A. S., Spellberg, B. J., & Edwards, J. E. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283165fd1 · Cited by 264 · see citing works

Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

Piga, A. G., Galanello, R., Forni, G. L., Cappellini, M. D., Origa, R., Zappu, A., Donato, G., Bordone, E., Lavagetto, A., Zanaboni, L., et al. (2006) · PubMed · Cited by 263 · see citing works

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents

Richardson, D. R., Kalinowski, D. S., Lau, S. L., Jansson, P. J., & Lovejoy, D. B. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.003 · Cited by 260 · see citing works

Protective effects of the green tea polyphenol (−)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils

Lee, S., Suh, S., & Kim, S.-P. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01159-9 · Cited by 245 · see citing works

Dealing with iron: Common structural principles in proteins that transport iron and heme

Baker, H. M., Anderson, B. F., & Baker, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0637295100 · Cited by 243 · see citing works

Neuroprotective Strategies in Parkinson???s Disease

Mandel, S. A., Grünblatt, E., Riederer, P. F., Gerlach, M., Levites, Y., & Youdim, M. B. H. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00004 · Cited by 238 · see citing works

Dietary flavonoid iron complexes as cytoprotective superoxide radical scavengers

Moridani, M. Y., Pourahmad, J., Bui, H. Q., Siraki, A. G., & O'Brien, P. J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01241-8 · Cited by 237 · see citing works

The Role of Iron Chelation in Cancer Therapy

Buss, J. L., Torti, F. M., & Torti, S. V. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457638 · Cited by 236 · see citing works

Apocynin protects against global cerebral ischemia–reperfusion-induced oxidative stress and injury in the gerbil hippocampus

Wang, Q., Tompkins, K. D., Simonyi, Á., Korthuis, R. J., Sun, A. Y., & Sun, G. Y. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.060 · Cited by 235 · see citing works

Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study

Porter, J. B., Galanello, R., Saglio, G. N., Neufeld, E. J., Vichinsky, E. P., Cappellini, M. D., Olivieri, N. F., Piga, A. G., Cunningham, M. J., Soulières, D., et al. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00985.x · Cited by 235 · see citing works

Cellular iron: Ferroportin is the only way out

Ganz, T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.02.005 · Cited by 232 · see citing works

Iron-binding properties of plant phenolics and cranberry's bio-effects

Guo, M., Perez, C., Wei, Y., Rapoza, E., Su, G. M., Bou‐Abdallah, F., & Chasteen, N. D. (2007) · Dalton Transactions · doi:10.1039/b705136k · Cited by 227 · see citing works

Botanical Phenolics and Brain Health

Sun, A. Y., Wang, Q., Simonyi, Á., & Sun, G. Y. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8052-z · Cited by 225 · see citing works

Long-Term Administration of Green Tea Catechins Improves Spatial Cognition Learning Ability in Rats

Haque, A. M., Hashimoto, M., Katakura, M., Tanabe, Y., Hara, Y., & Shido, O. (2006) · Journal of Nutrition · doi:10.1093/jn/136.4.1043 · Cited by 224 · see citing works

Hepatotoxicity of Iron Overload: Mechanisms of Iron-Induced Hepatic Fibrogenesis

Ramm, G. A., & Ruddell, R. G. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923315 · Cited by 221 · see citing works

Pathways of Iron Absorption

Conrad, M. E., & Umbreit, J. N. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0564 · Cited by 219 · see citing works

Role of the hypoxia inducible factors HIF in iron metabolism

Peyssonnaux, C., Nizet, V., & Johnson, R. S. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5145 · Cited by 217 · see citing works

Iron chelation in the biological activity of curcumin

Jiao, Y., Wilkinson, J. C., Pietsch, E. C., Buss, J. L., Wang, W., Planalp, R. P., Torti, F. M., & Torti, S. V. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.11.003 · Cited by 211 · see citing works

The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress‐Mediated Diseases

Vı́tek, L., & Schwertner, H. A. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)43001-8 · Cited by 208 · see citing works

Iron-binding and anti-Fenton properties of baicalein and baicalin

Perez, C. A., Wei, Y., & Guo, M. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.11.003 · Cited by 207 · see citing works

Iron Chelators in Cancer Chemotherapy

Buss, J. L., Greene, B. T., Turner, J., Torti, F. M., & Torti, S. V. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387269 · Cited by 199 · see citing works

Chelators at the cancer coalface: Desferrioxamine to Triapine and beyond

Yu, Y., Wong, J., Lovejoy, D. B., Kalinowski, D. S., & Richardson, D. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1954 · Cited by 195 · see citing works

Pathways underlying iron accumulation in human nonalcoholic fatty liver disease

Aigner, E., Theurl, I., Theurl, M., Lederer, D., Haufe, H., Dietze, O., Strasser, M., Datz, C., & Weiss, G. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1374 · Cited by 190 · see citing works

Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease

Reznichenko, L., Amit, T., Zheng, H., Avramovich‐Tirosh, Y., Youdim, M. B. H., Weinreb, O., & Mandel, S. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03770.x · Cited by 189 · see citing works

Protective effects of tea polyphenols against oxidative damage to red blood cells

Grinberg, L. N., Newmark, H., Kitrossky, N., Rahamim, E., Chevion, M., & Rachmilewitz, E. A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00155-x · Cited by 187 · see citing works

The Role of Zinc, Copper and Iron in the Pathogenesis of Diabetes and Diabetic Complications: Therapeutic Effects by Chelators

Zheng, Y., Li, X.-K., Wang, Y., & Cai, L. (2008) · Hemoglobin · doi:10.1080/03630260701727077 · Cited by 181 · see citing works

Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion‐dependent thalassemia: a literature review

Delea, T. E., Edelsberg, J., Sofrygin, O., Thomas, S. K., Baladi, J., Phatak, P. D., & Coates, T. D. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01416.x · Cited by 180 · see citing works

Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major

Davis, B. A., O'Sullivan, C., Jarritt, P. H., & Porter, J. B. (2004) · Blood · doi:10.1182/blood-2003-08-2841 · Cited by 180 · see citing works

The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis

Kelly, P., Moeller, B. J., Juneja, J., Booden, M. A., Der, C. J., Daaka, Y., Dewhirst, M. W., Fields, T. A., & Casey, P. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510254103 · Cited by 179 · see citing works

Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury

Sato, M., Maulik, G., Ray, P. S., Bagchi, D., & Das, D. K. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0961 · Cited by 178 · see citing works

Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance

Liu, G., Men, P., Harris, P. L. R., Rolston, R. K., Perry, G. L., & Smith, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.020 · Cited by 177 · see citing works

Iron in arterial plaque: A modifiable risk factor for atherosclerosis

Sullivan, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.06.005 · Cited by 176 · see citing works

Iron Depletion by Deferoxamine Up-Regulates Glucose Uptake and Insulin Signaling in Hepatoma Cells and in Rat Liver

Dongiovanni, P., Valenti, L. V. C., Fracanzani, A. L., Gatti, S., Cairo, G., & Fargion, S. R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070097 · Cited by 169 · see citing works

The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents III: The Effect of the Ligands on Molecular Targets Involved in Proliferation

Darnell, G. A., & Richardson, D. R. (1999) · Blood · doi:10.1182/blood.v94.2.781 · Cited by 168 · see citing works

Regulatory effects of ferritin on angiogenesis

Coffman, L. G., Parsonage, D., D'Agostino, R., Torti, F. M., & Torti, S. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812010106 · Cited by 168 · see citing works

Structure-activity relationship of flavonoids with superoxide scavenging activity

Hu, J., Calomme, M. R., Lasure, A., Bruyne, T. D., Pieters, L. A. C., Vlietinck, A. J., & Berghe, D. A. V. (1995) · Biological Trace Element Research · doi:10.1007/bf02790134 · Cited by 166 · see citing works

The toxicology and safety of apple polyphenol extract

Shoji, T., Akazome, Y., Kanda, T., & Ikeda, M. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.02.008 · Cited by 163 · see citing works

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert�panel�review

Swain, S. M., & Vici, P. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0498-7 · Cited by 155 · see citing works

The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells

Rao, V. A., Klein, S. R., Agama, K., Toyoda, E., Adachi, N., Pommier, Y. G., & Shacter, E. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1437 · Cited by 155 · see citing works

Targeting Multiple Neurodegenerative Diseases Etiologies with Multimodal-Acting Green Tea Catechins

Mandel, S. A., Amit, T., Kalfon, L., Reznichenko, L., & Youdim, M. B. H. (2008) · Journal of Nutrition · doi:10.1093/jn/138.8.1578s · Cited by 148 · see citing works

Antioxidant and cytotoxic activities of naturally occurring phenolic and related compounds: A comparative study

Rao, Y. K., Geethangili, M., Fang, S., & Tzeng, Y. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.03.012 · Cited by 144 · see citing works

Chemical, Biological and Clinical Aspects of Dexrazoxane and Other Bisdioxopiperazines

Hasinoff, B. B., Hellmann, K., Herman, E., & Ferrans, V. J. (1998) · Current Medicinal Chemistry · doi:10.2174/0929867305666220314194045 · Cited by 141 · see citing works

Neuroprotective effects of (−)‐epigallocatechin gallate after hypoxia‐ischemia‐induced brain damage: novel mechanisms of action

Sutherland, B. A., Shaw, O. M., Clarkson, A. N., Jackson, D. M., Sammut, I. A., & Appleton, I. (2004) · The FASEB Journal · doi:10.1096/fj.04-2806fje · Cited by 140 · see citing works

Phase I and Pharmacokinetic Study of the Ribonucleotide Reductase Inhibitor, 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, Administered by 96-Hour Intravenous Continuous Infusion

Wadler, S., Makower, D., Clairmont, C., Lambert, P., Fehn, K., & Sznol, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.158 · Cited by 140 · see citing works

Structure−Activity Relationships of Tea Compounds against Human Cancer Cells

Friedman, M., Mackey, B. E., Kim, H., Lee, I., Lee, K.-R., Lee, S., Kozukue, E., & Kozukue, N. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062276h · Cited by 136 · see citing works

An Overview of the Health Effects of Isoflavones with an Emphasis on Prostate Cancer Risk and Prostate-Specific Antigen Levels

Messina, M. J., Küçük, Ö., & Lampe, J. W. (2006) · Journal of AOAC International · doi:10.1093/jaoac/89.4.1121 · Cited by 131 · see citing works

Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?

Hasinoff, B. B., & Herman, E. H. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0023-3 · Cited by 123 · see citing works

ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPα and STAT-3

Choi, S.-O., Cho, Y.-S., Kim, H.-L., & Park, J.-W. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.137 · Cited by 122 · see citing works

Molecular biology of iron acquisition in Saccharomyces cerevisiae

Askwith, C. C., de Silva, D., & Kaplan, J. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02485.x · Cited by 121 · see citing works

Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells

Kawabata, H., Nakamaki, T., Ikonomi, P., Smith, R. D., Germain, R. S., & Koeffler, H. P. (2001) · Blood · doi:10.1182/blood.v98.9.2714 · Cited by 120 · see citing works

Potent Antitumor Activity of Novel Iron Chelators Derived from Di-2-Pyridylketone Isonicotinoyl Hydrazone Involves Fenton-Derived Free Radical Generation

Chaston, T. B., Watts, R., Yuan, J. J., & Richardson, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0865 · Cited by 120 · see citing works

Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid

Zhang, Z., Wei, T., Hou, J., Li, G.-S., Yu, S., & Xin, W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01597-8 · Cited by 118 · see citing works

Bioactive Dietary Polyphenolic Compounds Reduce Nonheme Iron Transport across Human Intestinal Cell Monolayers

Kim, E., Ham, S., Shigenaga, M. K., & Han, O. (2008) · Journal of Nutrition · doi:10.1093/jn/138.9.1647 · Cited by 117 · see citing works

Green Tea Protects Rats against Autoimmune Arthritis by Modulating Disease-Related Immune Events

Kim, H. R., Rajaiah, R., Wu, Q., Satpute, S. R., Tan, M. T., Simon, J. E., Berman, B., & Moudgil, K. D. (2008) · Journal of Nutrition · doi:10.3945/jn.108.089912 · Cited by 117 · see citing works

Deferasirox

Yang, L. P. H., Keam, S. J., & Keating, G. M. (2007) · Drugs · doi:10.2165/00003495-200767150-00007 · Cited by 114 · see citing works

Clinical application of deferasirox: Practical patient management

Vichinsky, E. P. (2007) · American Journal of Hematology · doi:10.1002/ajh.21119 · Cited by 114 · see citing works

Identification of Hypoxically Inducible mRNAs in HeLa Cells Using Differential‐Display PCR

O'rourke, J. F., Pugh, C. W., Bartlett, S. M., & Ratcliffe, P. J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00403.x · Cited by 113 · see citing works

Iron: A New Target for Pharmacological Intervention in Neurodegenerative Diseases

Whitnall, M., & Richardson, D. R. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.008 · Cited by 113 · see citing works

The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway.

Lee, J. H., Li, Y. C., Ip, S., Hsu, S., Chang, N.-W., Tang, N.-Y., Yu, C. S., Chou, S., Lin, S.-S., Lin, C. C., et al. (2008) · PubMed · Cited by 112 · see citing works

Deferoxamine Therapy in High-Ferritin Diabetes

Cutler, P. (1989) · Diabetes · doi:10.2337/diab.38.10.1207 · Cited by 111 · see citing works

Procyanidines fromVitis viniferaSeeds Protect Rabbit Heart from Ischemia/Reperfusion Injury: Antioxidant Intervention and/or Iron and Copper Sequestering Ability

Facino, R. M., Carini, M., Aldini, G., Berti, F., Rossoni, G., Bombardelli, E., & Morazzoni, P. (1996) · Planta Medica · doi:10.1055/s-2006-957956 · Cited by 110 · see citing works

Combined inhibition of estrogen‐dependent human breast carcinoma by soy and tea bioactive components in mice

Zhou, J., Yu, L., Mai, Z., & Blackburn, G. L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11549 · Cited by 109 · see citing works

Characterization of Serum Ferritin in Iron Overload: Possible Identity to Natural Apoferritin

Arosio, P., YOKOTA, M., & Drysdale, J. (1977) · British Journal of Haematology · doi:10.1111/j.1365-2141.1977.tb00640.x · Cited by 107 · see citing works

Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury1

de Vries, B., Walter, S. J., von Bonsdorff, L., Wolfs, T. G. A. M., van Heurn, E. L. W., Parkkinen, J., & Buurman, W. A. (2004) · Transplantation · doi:10.1097/01.tp.0000115002.28575.e7 · Cited by 105 · see citing works

Effects of dietary baicalin supplementation on iron overload-induced mouse liver oxidative injury

Zhao, Y., Li, H., Gao, Z., & Xu, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.060 · Cited by 103 · see citing works

Identification of the di‐pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti‐tumour agents

Becker, E., Lovejoy, D. B., Greer, J. M., Watts, R., & Richardson, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705089 · Cited by 103 · see citing works

Antiparkinson drug – Mucuna pruriens shows antioxidant and metal chelating activity

Dhanasekaran, M., Tharakan, B., & Manyam, B. V. (2007) · Phytotherapy Research · doi:10.1002/ptr.2109 · Cited by 102 · see citing works

Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis

Swaminathan, S., High, W. A., Ranville, J. F., Horn, T. D., Hiatt, K. M., Thomas, M., Brown, H. H., & Shah, S. V. (2008) · Kidney International · doi:10.1038/ki.2008.76 · Cited by 102 · see citing works

Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells.

Lee, H. Z., Leung, H. W. C., Lai, M. Y., & Wu, C. H. (2005) · PubMed · Cited by 102 · see citing works

Iron storage disease: Facts, fiction and progress

Beutler, E. (2007) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2007.03.009 · Cited by 101 · see citing works

Concepts and goals in the management of transfusional iron overload

Porter, J. B. (2007) · American Journal of Hematology · doi:10.1002/ajh.21100 · Cited by 100 · see citing works

Tumor Cell Cytotoxicity of a Novel Metal Chelator

Torti, S. V., Torti, F. M., Whitman, S. P., Brechbiel, M. W., Park, G., & Planalp, R. P. (1998) · Blood · doi:10.1182/blood.v92.4.1384 · Cited by 98 · see citing works

Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

Lovejoy, D., & Richardson, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457557 · Cited by 98 · see citing works

The influence of different protein sources on phytate inhibition of nonheme-iron absorption in humans

Reddy, M., Hurrell, R. F., Juillerat, M., & Cook, J. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.2.203 · Cited by 97 · see citing works

Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells

Cao, X., Qin, J., Xie, Y., Khan, O. Y., Dowd, F. J., Scofield, M., Lin, M.-F., & Tu, Y. (2006) · Oncogene · doi:10.1038/sj.onc.1209408 · Cited by 97 · see citing works

ANTI‐OXIDANT MECHANISMS OF KOLAVIRON: STUDIES ON SERUM LIPOPROTEIN OXIDATION, METAL CHELATION AND OXIDATIVE MEMBRANE DAMAGE IN RATS

Farombi, E. O., & Nwaokeafor, I. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.0305-1870.2005.04248.x · Cited by 96 · see citing works

Effect of enhanced iron chelation therapy on glucose metabolism in patients with β‐thalassaemia major

Farmaki, K., Angelopoulos, N., Anagnostopoulos, G., Gotsis, E. D., Rombopoulos, G., & Tolis, G. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06203.x · Cited by 96 · see citing works

Iron and the liver: Update 2008

Deugnier, Y., Brissot, P., & Loréal, O. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.014 · Cited by 95 · see citing works

Dietary supplementation of baicalin and quercetin attenuates iron overload induced mouse liver injury

Zhang, Y., Li, H., Zhao, Y., & Gao, Z. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.067 · Cited by 95 · see citing works

Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin–Fe(III)–water and Curcumin–Fe(II)–water

Bernabé-Pineda, M., Ramı́rez-Silva, M. T., Romero-Romo, M., Vergara, E. G., & Rojas-Hernándéz, A. (2004) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/s1386-1425(03)00344-5 · Cited by 95 · see citing works

In Vitro Characterization of Enzymatic Properties and Inhibition of the p53R2 Subunit of Human Ribonucleotide Reductase

Shao, J., Zhou, B., Zhu, L., Qiu, W., Yuan, Y., Xi, B., & Yen, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3048 · Cited by 93 · see citing works

Cranberry proanthocyanidins associate with low‐density lipoprotein and inhibit in vitro Cu2+‐induced oxidation

Porter, M. L., Krueger, C. G., Wiebe, D. A., Cunningham, D. G., & Reed, J. D. (2001) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.940 · Cited by 92 · see citing works

Curcuma Oil: Reduces Early Accumulation of Oxidative Product and is Anti-apoptogenic in Transient Focal Ischemia in Rat Brain

Rathore, P., Dohare, P., Varma, S., Ray, A., Sharma, U., Jaganathanan, N. R., & Ray, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9515-6 · Cited by 91 · see citing works

Apocynin Attenuates Cerebral Infarction after Transient Focal Ischaemia in Rats

Tang, L.-L., Ye, K., Yang, X., & Zheng, J. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500411 · Cited by 90 · see citing works

Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells

Noulsri, E., Richardson, D. R., Lerdwana, S., Fucharoen, S., Yamagishi, T., Kalinowski, D. S., & Pattanapanyasat, K. (2008) · American Journal of Hematology · doi:10.1002/ajh.21350 · Cited by 89 · see citing works

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

Yen, Y., Margolin, K. A., Doroshow, J. H., Fishman, M., Johnson, B. L., Clairmont, C., Sullivan, D., & Sznol, M. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0821-2 · Cited by 89 · see citing works

The Protective Mechanism of Ligustrazine Against Renal Ischemia/Reperfusion Injury

Li, F., Ke, N., Cheng, F., Guo, Y., Li, S., Li, Q., & Li, Y. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.04.005 · Cited by 87 · see citing works

Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH)

Fabio, G., Minonzio, F., Delbini, P., Bianchi, A., & Cappellini, M. D. (2006) · Blood · doi:10.1182/blood-2006-04-016949 · Cited by 85 · see citing works

Iron chelation treatment with combined therapy with deferiprone and deferioxamine: A 12-month trial

Kattamis, A., Ladis, V., Berdousi, H., Kelekis, N., Alexopoulou, E., Papasotiriou, I., Drakaki, K., Kaloumenou, I., Galani, A., & KATTAMIS, C. A. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.11.002 · Cited by 85 · see citing works

Evaluation of desferrithiocin and its synthetic analogs as orally effective iron chelators

Bergeron, R. J., Wiegand, J., Dionis, J. B., Egli-Karmakka, M., Frei, J., Huxley‐Tencer, A., & PETER, H. H. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a023 · Cited by 84 · see citing works

Synthesis and Cytotoxicity Evaluation of Some 8-Hydroxyquinoline Derivatives

Shen, A., Wu, S., & Chiu, C.-T. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991772826 · Cited by 83 · see citing works

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells

Molina‐Holgado, F., Gaeta, A., Francis, P. T., Williams, R. J., & Hider, R. C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05332.x · Cited by 82 · see citing works

Soy Protein and Isoflavones Influence Adiposity and Development of Metabolic Syndrome in the Obese Male ZDF Rat

Davis, J. E., Higginbotham, A., O’Connor, T., Moustaïd‐Moussa, N., Tebbe, A., Kim, Y., Cho, K. W., Shay, N. F., Adler, S., Peterson, R. G., et al. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000100820 · Cited by 82 · see citing works

Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors

Su, Y., Simmen, F. A., Xiao, R., & Simmen, R. C. M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00023.2007 · Cited by 82 · see citing works

Transfusion independence in patients with myelodysplastic syndromes

Balducci, L. (2006) · Cancer · doi:10.1002/cncr.21860 · Cited by 81 · see citing works

Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats

Weisburger, J. H., Rivenson, A., Garr, K., & Aliaga, C. A. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04693-4 · Cited by 81 · see citing works

Iron chelators can protect against oxidative stress through ferryl heme reduction

Reeder, B. J., Hider, R. C., & Wilson, M. T. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.006 · Cited by 79 · see citing works

Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy

Leitch, H. A. (2007) · Leukemia Research · doi:10.1016/s0145-2126(07)70460-5 · Cited by 79 · see citing works

Quercetin Activates an Angiogenic Pathway, Hypoxia Inducible Factor (HIF)-1-Vascular Endothelial Growth Factor, by Inhibiting HIF-Prolyl Hydroxylase: a Structural Analysis of Quercetin for Inhibiting HIF-Prolyl Hydroxylase

Jeon, H., Kim, H., Choi, D., Kim, D., Park, S.-Y., Kim, Y.-J., Kim, Y. M., & Jung, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034041 · Cited by 79 · see citing works

Effect of ligustrazine on ischemia-reperfusion injury in murine kidney

Feng, L., Xiong, Y., Cheng, F., Zhang, L., Li, S., & Li, Y. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.07.050 · Cited by 78 · see citing works

A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant–iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate

Weinreb, O., Amit, T., & Youdim, M. B. H. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.011 · Cited by 78 · see citing works

Light and shadows in the iron chelation treatment of haematological diseases

Maggio, A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06666.x · Cited by 77 · see citing works

Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation

Turner, J. (2005) · Blood · doi:10.1182/blood-2005-03-1263 · Cited by 76 · see citing works

Breast Cancer Prevention by Green Tea Catechins and Black Tea Theaflavins in the C3(1) SV40 T,t Antigen Transgenic Mouse Model Is Accompanied by Increased Apoptosis and a Decrease in Oxidative DNA Adducts

Kaur, S., Greaves, P., Cooke, D. N., Edwards, R., Steward, W. P., Gescher, A. J., & Marczylo, T. H. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0633342 · Cited by 72 · see citing works

Iron chelators ICL670 and 311 inhibit HIV-1 transcription

Debebe, Z., Ammosova, T., Jerebtsova, M., Kurantsin‐Mills, J., Niu, X., Charles, S. M., Richardson, D. R., Ray, P. E., Gordeuk, V. R., & Nekhai, S. A. (2007) · Virology · doi:10.1016/j.virol.2007.06.011 · Cited by 72 · see citing works

Theaflavin Ameliorates Cerebral Ischemia‐Reperfusion Injury in Rats Through Its Anti‐Inflammatory Effect and Modulation of STAT‐1

Cai, F., Li, C., Wu, J., Chen, J., Liu, C., Min, Q., Yu, W., Ouyang, C., & Chen, J. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/30490 · Cited by 71 · see citing works

Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines

Rakba, N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.943 · Cited by 70 · see citing works

Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis

Lahiry, L., Saha, B., Chakraborty, J., Bhattacharyya, S., Chattopadhyay, S., Banerjee, S., Choudhuri, T., Mandal, D. P., Bhattacharyya, A., Sa, G., et al. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0213-x · Cited by 69 · see citing works

Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin

Hoke, E. M., Maylock, C. A., & Shacter, E. B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.029 · Cited by 68 · see citing works

Synergistic Anion and Metal Binding to the Ferric Ion-binding Protein from Neisseria gonorrhoeae

Guo, M., Harvey, I., Yang, W., Coghill, L. S., Campopiano, D. J., Parkinson, J. A., MacGillivray, R. T. A., Harris, W. R., & Sadler, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208776200 · Cited by 67 · see citing works

Inhibition of lipoxygenase by soy isoflavones: Evidence of isoflavones as redox inhibitors

Gangadhariah, M. H., Singh, S. A., & Rao, A. G. A. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.02.013 · Cited by 66 · see citing works

A Cooperative Interaction between Soy Protein and Its Isoflavone-Enriched Fraction Lowers Hepatic Lipids in Male Obese Zucker Rats and Reduces Blood Platelet Sensitivity in Male Sprague-Dawley Rats

Peluso, M. R., Winters, T. A., Shanahan, M. F., & Banz, W. J. (2000) · Journal of Nutrition · doi:10.1093/jn/130.9.2333 · Cited by 66 · see citing works

Green tea catechins as brain-permeable, non toxic iron chelators to “iron out iron” from the brain

Mandel, S. A., Weinreb, O., Reznichenko, L., Kalfon, L., & Amit, T. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_26 · Cited by 65 · see citing works

Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands

Bernhardt, P. V., Wilson, G. J., Sharpe, P. C., Kalinowski, D. S., & Richardson, D. R. (2007) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-007-0300-4 · Cited by 65 · see citing works

The Design of Orally Active Iron Chelators

HIDER, R. C., & ZHOU, T. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.017 · Cited by 64 · see citing works

Iron chelation as a potential therapy for neurodegenerative disease

Hider, R. C., Ma, Y., Molina‐Holgado, F., Gaeta, A., & Roy, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361304 · Cited by 64 · see citing works

Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation

Ballardini, G., Groff, P., Zoli, M., Bianchi, G., Giostra, F., Francesconi, R., Lenzi, M., Zauli, D., Cassani, F., & Bianchi, F. P. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80061-3 · Cited by 64 · see citing works

Black tea and mammary gland carcinogenesis by 7,12- dimethylbenz[a]anthracene in rats fed control or high fat diets

Rogers, A. E. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1269 · Cited by 64 · see citing works

Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women

Hanson, L. N., Engelman, H. M., Alekel, D. L., Schalinske, K. L., Kohut, M. L., & Reddy, M. B. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.774 · Cited by 63 · see citing works

Hemoglobin Induced Apolipoprotein B Crosslinking in Low-Density Lipoprotein Peroxidation

Miller, Y. I., Felikman, Y., & Shaklai, N. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0073 · Cited by 63 · see citing works

Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis

Tarao, K., Shimizu, A., Ohkawa, S., Harada, M., Ito, Y., Tamai, S., Kuni, Y., Okamoto, N., Inoue, T., & Kanisawa, M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90852-p · Cited by 60 · see citing works

What is new in iron overload?

Vermylen, C. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0604-y · Cited by 58 · see citing works

Safety monitoring of cardiac and hepatic systems in β‐thalassemia patients with chelating treatment in Taiwan*

Peng, C., Chow, K., Chen, J., Chiang, Y., Lin, T., & Tsai, C. (2003) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2003.00071.x · Cited by 58 · see citing works

A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model

Bergeron, R. J., Streiff, R., Creary, E., Daniels, R. J., King, W., Luchetta, G. R., Wiegand, J. S., Moerker, T., & Peter, H. (1993) · Blood · doi:10.1182/blood.v81.8.2166.bloodjournal8182166 · Cited by 58 · see citing works

Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma

Brard, L., Granai, C. O., & Swamy, N. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.07.129 · Cited by 57 · see citing works

Comparison of the Inflammatory Burden of Truly Asymptomatic Carotid Atheroma with Atherosclerotic Plaques in Patients with Asymptomatic Carotid Stenosis Undergoing Coronary Artery Bypass Grafting: An Ultrasmall Superparamagnetic Iron Oxide Enhanced Magnetic Resonance Study

Tang, T. Y., Howarth, S. P. S., Miller, S. R., Graves, M. J., U-King-Im, J., Li, Z., Walsh, S. R., Hayes, P. D., Varty, K., & Gillard, J. H. (2008) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2007.10.019 · Cited by 55 · see citing works

Iron Chelation Suppresses Ferritin Upregulation and Attenuates Vascular Dysfunction in the Aorta of Angiotensin II–Infused Rats

Ishizaka, N., Saito, K., Mori, I., Matsuzaki, G., Ohno, M., & Nagai, R. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181763.57495.2b · Cited by 55 · see citing works

Iron and cancer: more ore to be mined

Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · see citing works

Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function

Hoes, M. F., Grote Beverborg, N., Kijlstra, J. D., Kuipers, J., Swinkels, D. W., Giepmans, B. N. G., Rodenburg, R. J., van Veldhuisen, D. J., de Boer, R. A., & van der Meer, P. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1154 · Cited by 333 · see citing works

New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms

Borges, A. D. S., Abreu, A. C., Días, C., Saavedra, M. J., Borges, F., & Simões, M. V. (2016) · Molecules · doi:10.3390/molecules21070877 · Cited by 310 · see citing works

Use of polyphenol-rich grape by-products in monogastric nutrition. A review

Brenes, A., Viveros, A., Chamorro, S., & Arija, I. (2015) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2015.09.016 · Cited by 321 · see citing works

Iron as a central player and promising target in cancer progression

Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works

Deferasirox alleviates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and improving intestinal microbiota

Wu, Y., Ran, L., Yang, Y., Gao, X., Peng, M., Liu, S., Sun, L., Wan, J., Wang, Y., Yang, K., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121312 · Cited by 231 · see citing works

The role of lysosomes in iron metabolism and recycling

Kurz, T., Eaton, J. W., & Brunk, U. T. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.08.016 · Cited by 207 · see citing works

Redox Imbalance in Inflammation: The Interplay of Oxidative and Reductive Stress

Bellanti, F., Coda, A. R. D., Trecca, M. I., Buglio, A. L., Serviddio, G., & Vendemiale, G. (2025) · Antioxidants · doi:10.3390/antiox14060656 · Cited by 212 · see citing works

Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients

Macciò, A., Gramignano, G., Cherchi, M. C., Tanca, L., Melis, L., & Madeddu, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63276-1 · Cited by 182 · see citing works

Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator

Bellotti, D., & Remelli, M. (2021) · Molecules · doi:10.3390/molecules26113255 · Cited by 152 · see citing works

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage

Farr, A. C., & Xiong, M. P. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00474 · Cited by 149 · see citing works

Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals

Grillo, A. S., SantaMaria, A. M., Kafina, M. D., Cioffi, A. G., Huston, N. C., Han, M., Seo, Y. A., Yien, Y. Y., Nardone, C., Menon, A. V., et al. (2017) · Science · doi:10.1126/science.aah3862 · Cited by 147 · see citing works

Deferoxamine: An Angiogenic and Antioxidant Molecule for Tissue Regeneration

Holden, P., & Nair, L. S. (2019) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0111 · Cited by 128 · see citing works

The Chelating Ability of Plant Polyphenols Can Affect Iron Homeostasis and Gut Microbiota

Scarano, A., Laddomada, B., Blando, F., Santis, S. D., Verna, G., Chieppa, M., & Santino, A. (2023) · Antioxidants · doi:10.3390/antiox12030630 · Cited by 130 · see citing works

Beneficial attributes and adverse effects of major plant-based foods anti-nutrients on health: A review

Nath, H., Samtiya, M., & Dhewa, T. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200147 · Cited by 124 · see citing works

The Role of Iron, Its Metabolism and Ferroptosis in Traumatic Brain Injury

Tang, S., Gao, P., Chen, H., Zhou, X., Ou, Y., & He, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.590789 · Cited by 119 · see citing works

Biophysical and in vitro absorption studies of iron chelating peptide from barley proteins

Eckert, E., Lu, L., Unsworth, L. D., Chen, L., Xie, J., & Xu, R. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.06.011 · Cited by 108 · see citing works

Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles

Bardestani, A., Ebrahimpour, S., Esmaeili, A., & Esmaeili, A. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01059-0 · Cited by 105 · see citing works

Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development

Marchetti, M., Bei, O. D., Bettati, S., Campanini, B., Kovachka, S., Gianquinto, E., Spyrakis, F., & Ronda, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062145 · Cited by 92 · see citing works

A lignin-derived material improves plant nutrient bioavailability and growth through its metal chelating capacity

Liu, Q., Kawai, T., Inukai, Y., Aoki, D., Feng, Z., Xiao, Y., Fukushima, K., Lin, X., Shi, W., Busch, W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40497-2 · Cited by 95 · see citing works

Advances in iron chelation: an update

Heli, H., Mirtorabi, S., & Karimian, K. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.569493 · Cited by 92 · see citing works

Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer’s disease

Barbosa, F. A. R., Canto, R. F. S., Saba, S., Rafique, J., & Braga, A. L. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.031 · Cited by 86 · see citing works

Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression

Mertens, C., Akam, E. A., Rehwald, C., Brüne, B., Tomat, E., & Jung, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166164 · Cited by 83 · see citing works

Hypoxia Mimetic Agents for Ischemic Stroke

Davis, C. K., Jain, S. A., Bae, O., Majid, A., & Rajanikant, G. K. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00175 · Cited by 80 · see citing works

An oral “Super probiotics” with versatile self-assembly adventitia for enhanced intestinal colonization by autonomous regulating the pathological microenvironment

Yang, J., Zhang, G., Yang, X., Peng, M., Ge, S., Tan, S., Wen, Z., Wang, Y., Wu, S., Liang, Y., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137204 · Cited by 78 · see citing works

Proanthocyanidin promotes functional recovery of spinal cord injury via inhibiting ferroptosis

Zhou, H., Yin, C., Zhang, Z., Tang, H., Shen, W., Zha, X., Gao, M., Sun, J., Xu, X., & Chen, Q. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101807 · Cited by 77 · see citing works

Iron (III)-Quercetin Complex: Synthesis, Physicochemical Characterization, and MRI Cell Tracking toward Potential Applications in Regenerative Medicine

Papan, P., Kantapan, J., Sangthong, P., Meepowpan, P., & Dechsupa, N. (2020) · Contrast Media & Molecular Imaging · doi:10.1155/2020/8877862 · Cited by 74 · see citing works

Recent advances in cancer treatment by iron chelators

Corcé, V., Gouin, S. G., Renaud, S., Gaboriau, F., & Deniaud, D. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.094 · Cited by 74 · see citing works

Role of Carbon Monoxide in Host–Gut Microbiome Communication

Hopper, C., Cruz, L. K. D. L., Lyles, K. V. M., Wareham, L. K., Gilbert, J. A., Eichenbaum, Z., Magierowski, M., Poole, R. K., Wollborn, J., & Wang, B. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00586 · Cited by 72 · see citing works

Parkinson’s Disease: The Mitochondria-Iron Link

Muñoz, Y., Carrasco, C. M., Campos, J., Aguirre, P., & Núñez, M. T. (2016) · Parkinson s Disease · doi:10.1155/2016/7049108 · Cited by 73 · see citing works

Iron chelators in cancer therapy

Ibrahim, O., & O’Sullivan, J. (2020) · BioMetals · doi:10.1007/s10534-020-00243-3 · Cited by 70 · see citing works

The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications

Kell, D. B., & Pretorius, E. (2022) · Biochemical Journal · doi:10.1042/bcj20220154 · Cited by 68 · see citing works

Natural iron chelators: Protective role in A549 cells of flavonoids-rich extracts of Citrus juices in Fe 3+ -induced oxidative stress

Ferlazzo, N., Visalli, G., Cirmi, S., Lombardo, G. E., Laganà, P., Pietro, A. D., & Navarra, M. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.03.005 · Cited by 67 · see citing works

A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases

Singh, Y. P., Pandey, A., Vishwakarma, S., & Modi, G. P. (2018) · Molecular Diversity · doi:10.1007/s11030-018-9878-4 · Cited by 67 · see citing works

Tannic acid (TA): A molecular tool for chelating and imaging labile iron

Phiwchai, I., Yuensook, W., Sawaengsiriphon, N., Krungchanuchat, S., & Pilapong, C. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.12.004 · Cited by 66 · see citing works

Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets

Schneidewind, T., Brause, A., Pahl, A., Burhop, A., Mejuch, T., Sievers, S., Waldmann, H., & Ziegler, S. (2020) · ChemBioChem · doi:10.1002/cbic.202000381 · Cited by 65 · see citing works

Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury

Jia, H., Liu, X., Cao, Y., Niu, H., Zhang, L., Li, R., Li, F., Sun, D., Shi, M., Wa, L., et al. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148383 · Cited by 65 · see citing works

Mining value from waste: Scandium and rare earth elements selective recovery from coal fly ash leach solutions

Mostajeran, M., Bondy, J.-M., Reynier, N., & Cameron, R. A. (2021) · Minerals Engineering · doi:10.1016/j.mineng.2021.107091 · Cited by 63 · see citing works

Natural Antioxidants in Anemia Treatment

Cotoraci, C. A., Ciceu, A., Sasu, A., & Hermenean, A. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041883 · Cited by 69 · see citing works

Lipocalin-2 and iron trafficking in the tumor microenvironment

Jung, M., Mertens, C., Bauer, R., Rehwald, C., & Brüne, B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.018 · Cited by 60 · see citing works

Targeting ferroptosis in ischemia/reperfusion renal injury

Thapa, K., Singh, T. G., & Kaur, A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02277-5 · Cited by 60 · see citing works

Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment

Qiao, O., Wang, X., Wang, Y., Li, N., & Gong, Y. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.016 · Cited by 60 · see citing works

Rice Bran Phytic Acid Induced Apoptosis Through Regulation of Bcl-2/Bax and p53 Genes in HepG2 Human Hepatocellular Carcinoma Cells

Al-Fatlawi, A. A. Y., Al-Fatlawi, A. A. Y., Irshad, M., Zafaryab, M., Rizvi, M. M. A., & Ahmad, A. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3731 · Cited by 60 · see citing works

Shedding a New Light on Skin Aging, Iron- and Redox-Homeostasis and Emerging Natural Antioxidants

Pourzand, C., Albieri, A., & Raczek, N. N. (2022) · Antioxidants · doi:10.3390/antiox11030471 · Cited by 62 · see citing works

A randomized double‐blind, placebo‐controlled study of therapeutic effects of silymarin in β‐thalassemia major patients receiving desferrioxamine

Moayedi, B., Gharagozloo, M., Esmaeil, N., Maracy, M. R., Hoorfar, H., & Jalaeikar, M. (2012) · European Journal Of Haematology · doi:10.1111/ejh.12061 · Cited by 59 · see citing works

Quercetin as a shuttle for labile iron

Baccan, M. M., Chiarelli-Neto, O., Pereira, R. M. S., & Espósito, B. P. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.11.014 · Cited by 59 · see citing works

Recent Advances in Hydrogen Peroxide Responsive Organoborons for Biological and Biomedical Applications

Saxon, E., & Peng, X. (2021) · ChemBioChem · doi:10.1002/cbic.202100366 · Cited by 57 · see citing works

Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms

Zhang, J., Zhao, H., Yao, G., Qiao, P., Li, L., & Wu, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111380 · Cited by 56 · see citing works

Substituent effect in salicylaldehyde 2-furoic acid hydrazones: Theoretical and experimental insights into DNA/BSA affinity modulation, antimicrobial and antioxidant activity

Zahirović, A., Fetahović, S., Feizi‐Dehnayebi, M., Bešta‐Gajević, R., Dizdar, M., Ostojić, J., & Roca, S. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138628 · Cited by 56 · see citing works

Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities

Jiang, X., Zhou, T., Bai, R., & Xie, Y. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01480 · Cited by 54 · see citing works

Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload

Bi, Y., Ajoolabady, A., Demillard, L. J., Yu, W., Hilaire, M. L., Zhang, Y., & Ren, J. T. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114661 · Cited by 54 · see citing works

Ultraviolet Light Protection: Is It Really Enough?

Farris, P. K., & Valacchi, G. (2022) · Antioxidants · doi:10.3390/antiox11081484 · Cited by 55 · see citing works

Inositol hexa phosphoric acid (phytic acid), a nutraceuticals, attenuates iron-induced oxidative stress and alleviates liver injury in iron overloaded mice

Bhowmik, A., Ojha, D., Goswami, D., Das, R., Chandra, N. S., Chatterjee, T. K., Chakravarty, A., Chakravarty, S., & Chattopadhyay, D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.125 · Cited by 53 · see citing works

Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson’s Disease and Intervention with Turmeric

van Rensburg, Z. J., Abrahams, S., Bardien, S., & Kenyon, C. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02516-5 · Cited by 51 · see citing works

The lipids

Turchini, G. M., Francis, D. S., Du, Z., Olsen, R. E., Ringø, E., & Tocher, D. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819587-1.00003-3 · Cited by 50 · see citing works

Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections

Chhabra, R., Saha, A., Chamani, A., Schneider, N., Shah, R., & Nanjundan, M. (2020) · Pharmaceuticals · doi:10.3390/ph13100275 · Cited by 51 · see citing works

Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond

Antić, D. R., Parčina, M., Gobin, I., & Didović, M. P. (2022) · Antibiotics · doi:10.3390/antibiotics11081105 · Cited by 49 · see citing works

An Untargeted Metabolomics Approach for Correlating Pulse Crop Seed Coat Polyphenol Profiles with Antioxidant Capacity and Iron Chelation Ability

Elessawy, F. M., Vandenberg, A., El‐Aneed, A., & Purves, R. W. (2021) · Molecules · doi:10.3390/molecules26133833 · Cited by 49 · see citing works

Metallophenolomics: A Novel Integrated Approach to Study Complexation of Plant Phenolics with Metal/Metalloid Ions

Fedenko, V. S., Landi, M., & Shemet, S. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911370 · Cited by 50 · see citing works

Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales

Williams, C. L., Caraballo‐Rodríguez, A. M., Allaband, C., Zarrinpar, A., Knight, R. D., & Gauglitz, J. M. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.08.012 · Cited by 46 · see citing works

Iron–Sulfur Cluster Biogenesis as a Critical Target in Cancer

Petronek, M. S., Spitz, D. R., & Allen, B. G. (2021) · Antioxidants · doi:10.3390/antiox10091458 · Cited by 46 · see citing works

Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer

Deng, Z., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7023 · Cited by 47 · see citing works

Advances in Hypoxia-Inducible Factor-1 α Stabilizer Deferoxamine in Tissue Engineering

Zhu, Y., Chang, B., Pang, Y., Wang, H., & Zhou, Y. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2022.0168 · Cited by 46 · see citing works

Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: Novel iron chelators with selective antiproliferative action

Macková, E., Hrušková, K., Bendová, P., Jirkovská, A., Jansová, H., Hašková, P., Kovařı́ková, P., Vávrová, K., & Šimůnek, T. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.03.010 · Cited by 45 · see citing works

Dendritic Cells Modulate Iron Homeostasis and Inflammatory Abilities Following Quercetin Exposure

Galleggiante, V., Santis, S. D., Cavalcanti, E., Scarano, A., Benedictis, M. D., Serino, G., Caruso, M. L., Mastronardi, M., Pinto, A., Campiglia, P., et al. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170112125355 · Cited by 44 · see citing works

Combating Iron Overload: A Case for Deferoxamine-Based Nanochelators

Jones, G., Goswami, S. K., Kang, H., Choi, H. S., & Kim, J. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0038 · Cited by 45 · see citing works

Broadening horizons: ferroptosis as a new target for traumatic brain injury

Wei, Z., Yu, H., Zhao, H., Wei, M., Xing, H., Pei, J., Yang, Y., & Ren, K. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad051 · Cited by 44 · see citing works

Iron in Lung Pathology

Zhang, V., Nemeth, E., & Kim, A. (2019) · Pharmaceuticals · doi:10.3390/ph12010030 · Cited by 57 · see citing works

Edible leaf extract of Ipomoea aquatica Forssk. (Convolvulaceae) attenuates doxorubicin-induced liver injury via inhibiting oxidative impairment, MAPK activation and intrinsic pathway of apoptosis

Dewanjee, S., Joardar, S., Bhattacharjee, N., Dua, T. K., Das, S., Kalita, J., & Manna, P. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.002 · Cited by 43 · see citing works

Effect of the oral iron chelator deferiprone in diabetic nephropathy rats

Zou, C., Liu, X., Liu, R., Wang, M., Sui, M., Mu, S.-H., Li, L., Ji, L., & Xie, R. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12420 · Cited by 42 · see citing works

Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions

Sharma, A., Vaghasiya, K., Ray, E., & Verma, R. K. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1374390 · Cited by 42 · see citing works

Iron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications

Rao, V. A. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4877 · Cited by 41 · see citing works

Ethylene, an early marker of systemic inflammation in humans

Paardekooper, L. M., van den Bogaart, G., Kox, M., Dingjan, I., Neerincx, A. H., Bendix, M. B., ter Beest, M., Harren, F. J. M., Risby, T. H., Pickkers, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05930-9 · Cited by 41 · see citing works

Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway

Chen, C., Liu, P., Duan, X., Cheng, M. S., & Xu, L. X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s193507 · Cited by 41 · see citing works

Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction Therapy

Lv, Q., Lin, J., Huang, H., Ma, B., Li, W., Chen, J., Wang, M., Wang, X., Fu, G., & Xiao, Y. (2024) · Advanced Science · doi:10.1002/advs.202305895 · Cited by 40 · see citing works

Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer

Lu, T., Tang, J., Shrestha, B., Heath, B. R., Li, H., Lei, Y. L., Ljungman, M. E., & Neamati, N. (2020) · Theranostics · doi:10.7150/thno.41792 · Cited by 40 · see citing works

Glutamyl cysteine dipeptide suppresses ferritin expression and alleviates liver injury in iron-overload rat model

Salama, S. A., Al-Harbi, M. S., Abdel‐Bakky, M. S., & Omar, H. A. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.006 · Cited by 40 · see citing works

Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc

Wijesinghe, T. P., Dharmasivam, M., Dai, C. C., & Richardson, D. R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105889 · Cited by 39 · see citing works

Proteomic profiling reveals that collismycin A is an iron chelator

Kawatani, M., Muroi, M., Wada, A., Inoue, G., Futamura, Y., Aono, H., Shimizu, K., Shimizu, T., Igarashi, Y., Takahashi, N., et al. (2016) · Scientific Reports · doi:10.1038/srep38385 · Cited by 36 · see citing works

Structural Basis for Xenosiderophore Utilization by the Human Pathogen Staphylococcus aureus

Endicott, N. P., Lee, E., & Wencewicz, T. A. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00036 · Cited by 34 · see citing works

Application of Deferoxamine in Tissue Regeneration Attributed to Promoted Angiogenesis

Shen, H., Ma, Y., Qiao, Y., Zhang, C., Chen, J., & Zhang, R. (2024) · Molecules · doi:10.3390/molecules29092050 · Cited by 34 · see citing works

The Role of Iron in DNA and Genomic Instability in Cancer, a Target for Iron Chelators That Can Induce ROS

Carter, A., Racey, S. N., & Veuger, S. J. (2022) · Applied Sciences · doi:10.3390/app121910161 · Cited by 33 · see citing works

Iron limitation in M. tuberculosis has broad impact on central carbon metabolism

Theriault, M., Pisu, D., Wilburn, K. M., Lê-Bury, G., MacNamara, C. W., Petrassi, H., Love, M., Rock, J., VanderVen, B. C., & Russell, D. (2022) · Communications Biology · doi:10.1038/s42003-022-03650-z · Cited by 27 · see citing works

Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma

Benadiba, J., Rosilio, C., Nebout, M., Heimeroth, V., Neffati, Z., Popa, A., Mary, D. A. S. G., Griessinger, E., Imbert, V., Sirvent, N., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1239257 · Cited by 32 · see citing works

Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors

Pizzamiglio, S., Bortoli, M. D., Taverna, E., Signore, M., Veneroni, S., Cho, W., Orlandi, R., Verderio, P., & Bongarzone, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020410 · Cited by 32 · see citing works

Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: Impact on interferon therapy

Darwish, S. F., El‐Bakly, W. M., El‐Naga, R. N., Awad, A. S., & El‐Demerdash, E. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.09.001 · Cited by 31 · see citing works

Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs

Potůčková, E., Jansová, H., Macháček, M., Jirkovská, A., Hašková, P., Tichotová, L., Richardson, V., Kalinowski, D. S., Richardson, D. R., & Šimůnek, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088754 · Cited by 30 · see citing works

The complex interplay between ferroptosis and atherosclerosis

Zhang, M., Li, J., & Hu, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117183 · Cited by 31 · see citing works

Synthetic and semi-synthetic antioxidants in medicine and food industry: a review

Tauchen, J., Huml, L., Jurášek, M., Regenstein, J. M., & Özoğul, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1599816 · Cited by 31 · see citing works

Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis

Thorburn, T., Aali, M., Kostek, L., LeTourneau-Paci, C., Colp, P., Zhou, J., Holbein, B. E., Hoskin, D. W., & Lehmann, C. (2017) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-179205 · Cited by 29 · see citing works

Deferoxamine-Modified Hybrid Materials for Direct Chelation of Fe(III) Ions from Aqueous Solutions and Indication of the Competitiveness of In Vitro Complexing toward a Biological System

Pawlaczyk, M., & Schroeder, G. (2021) · ACS Omega · doi:10.1021/acsomega.1c01411 · Cited by 27 · see citing works

Understanding the Potential and Risk of Bacterial Siderophores in Cancer

Pita-Grisanti, V., Chasser, K. M., Sobol, T., & Cruz-Monserrate, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.867271 · Cited by 24 · see citing works

Effects of iron deficiency and iron supplementation at the host-microbiota interface: Could a piglet model unravel complexities of the underlying mechanisms?

Abbas, M., Hayirli, Z., Drakesmith, H., Andrews, S. C., & Lewis, M. C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.927754 · Cited by 28 · see citing works

Metallomics for Alzheimer's disease treatment: Use of new generation of chelators combining metal-cation binding and transport properties

D'Acunto, C. W., Kaplánek, R., Gbelcová, H., Kejík, Z., Bříza, T., Vasina, L., Havlík, M., Ruml, T., & Král, V. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.084 · Cited by 26 · see citing works

Anti‐Cancer Iron(II) Complexes of Pentadentate N‐Donor Ligands: Cytotoxicity, Transcriptomics Analyses, and Mechanisms of Action

Kwong, W., Lok, C., Tse, C., Wong, E. L., & Che, C. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201404749 · Cited by 26 · see citing works

Solvent and spin state effects on molecular structure, IR spectra, binding energies and quantum chemical reactivity indices of deferiprone–ferric complex: DFT study

Kaviani, S., Izadyar, M., & Housaindokht, M. R. (2016) · Polyhedron · doi:10.1016/j.poly.2016.06.041 · Cited by 26 · see citing works

The Role of Iron in Atherosclerosis and its Association with Related Diseases

Gao, Y., Wang, B., Hu, M., Ma, Y., & Zheng, B. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01251-1 · Cited by 25 · see citing works

Small Molecule Chelators Reveal That Iron Starvation Inhibits Late Stages of Bacterial Cytokinesis

Santos, T. M. A., Lammers, M. G., Zhou, M., Sparks, I. L., Rajendran, M., Fang, D., Jesus, C. L. Y. D., Carneiro, G. F. R., Cui, Q., & Weibel, D. B. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00560 · Cited by 25 · see citing works

Forging New Antibiotic Combinations under Iron-Limiting Conditions

Chan, D. C. K., Guo, I., & Burrows, L. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01909-19 · Cited by 24 · see citing works

Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer

Orfanou, I.-M., Argyros, O., Papapetropoulos, A., Tseleni‐Balafouta, S., Vougas, K. N., & Tamvakopoulos, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.608201 · Cited by 25 · see citing works

Natural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases

Sheikh, N. W. A., Kosalge, S. B., Desai, T. R., Dewani, A. P., Mohale, D., & Tripathi, A. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98749 · Cited by 5 · see citing works

Iron chelators as therapeutic iron depletion agents

Birch, N. W., Wang, X., & Chong, H. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.11.1533 · Cited by 36 · see citing works

The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency

Kontoghiorghes, G. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094654 · Cited by 31 · see citing works

Deferoxamine and other iron chelators

Deravi, N., Norouzkhani, N., Keylani, K., Haghi, S. M., & Rafiei, S. K. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00591-1 · Cited by 2 · see citing works

Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology

Kontoghiorghe, C., Kolnagou, A., & Kontoghiorghes, G. J. (2015) · Molecules · doi:10.3390/molecules201119725 · Cited by 69 · see citing works